Kratom is a herbal extract derived from the leaves of a tropical tree native to Southeast Asia. It has gained popularity in recent years as a supplement that some claim can boost energy, improve mood, relieve pain, and help with opioid withdrawal. According to the Mayo Clinic, kratom can act as a stimulant at low doses, increasing alertness, while at higher doses, it can have sedative effects, potentially reducing pain and anxiety. However, its use is controversial due to potential health risks, including the possibility of addiction and dependence. Despite its growing use among individuals seeking alternatives to opioids or other medications, the U.S. Food and Drug Administration (FDA) has not approved kratom for any medical purpose. The Drug Enforcement Administration (DEA) has classified it as a "Drug and Chemical of Concern," highlighting its potential for abuse and lack of proven therapeutic benefits. Kratom is commonly sold in various places, including gas stations, smoke shops, and online retailers, making it widely accessible to consumers. The legal status of kratom varies significantly across the United States. While it is not classified as a controlled substance at the federal level under the Controlled Substances Act, several states have taken stricter measures. In some states, kratom is classified as a Schedule I controlled substance, making it illegal to sell, possess, or distribute. Other states have imposed age restrictions, such as requiring buyers to be at least 18 or 21 years old, while a few have outright banned it. In contrast, some states have no restrictions at all, allowing the sale and use of kratom without legal barriers. The differing regulations reflect the ongoing debate about kratom’s safety, efficacy, and potential for misuse. While some users report benefits, health experts caution about the lack of comprehensive research and the risks associated with its use. As the conversation around kratom continues, both lawmakers and public health officials are closely monitoring its impact and considering potential regulatory actions.